search icon
imrn-img

Immuron Ltd ADR, Common Stock

IMRN

NAQ

$1.97

+$0.02

(1.03%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$11.17M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
3.15K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.17
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.59 L
$5.96 H
$1.97

About Immuron Ltd ADR, Common Stock

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for digestive tract protection; and Protectyn, an immune supplement to help maintain a healthy digestive function and liver. It also develops Travelan (IMM-124E), which is in Phase II clinical trial, to reduce the risk of contracting travelers' diarrhea; and IMM-529, which is in Phase II clinical trial, for treating patients suffering from recurring clostridium difficile infection. The company has a collaboration with the US Naval Medical Research Command and Silver Spring, MD, USA to develop and clinically evaluate a therapeutic targeting Campylobacter and enterotoxigenic Escherichia coli infections; and a research collaboration with the Walter Reed Army Institute of Research to develop three Shigella-specific therapeutic products. The company was formerly known as Anadis Limited and changed its name to Immuron Limited in December 2008. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameIMRNSectorS&P500
1-Week Return-3.88%1.76%-2.5%
1-Month Return-7.31%0.33%-3.91%
3-Month Return-11.26%-8.58%-0.59%
6-Month Return-18.76%-4.26%3.45%
1-Year Return3.96%1.27%22.31%
3-Year Return-44.03%5.33%25%
5-Year Return-46.76%38.09%77.23%
10-Year Return-53.6%102.29%188.04%

Financials

Jun '20Jun '21Jun '22Jun '23Jun '245YR TREND
Total Revenue2.52M145.78K765.19K1.80M4.90M[{"date":"2020-06-30","value":51.37,"profit":true},{"date":"2021-06-30","value":2.97,"profit":true},{"date":"2022-06-30","value":15.61,"profit":true},{"date":"2023-06-30","value":36.81,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Cost of Revenue688.84K51.07K241.69K495.56K1.57M[{"date":"2020-06-30","value":43.99,"profit":true},{"date":"2021-06-30","value":3.26,"profit":true},{"date":"2022-06-30","value":15.43,"profit":true},{"date":"2023-06-30","value":31.64,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Gross Profit1.83M94.70K523.50K1.31M3.34M[{"date":"2020-06-30","value":54.83,"profit":true},{"date":"2021-06-30","value":2.84,"profit":true},{"date":"2022-06-30","value":15.69,"profit":true},{"date":"2023-06-30","value":39.23,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Gross Margin72.65%64.97%68.41%72.54%68.06%[{"date":"2020-06-30","value":100,"profit":true},{"date":"2021-06-30","value":89.42,"profit":true},{"date":"2022-06-30","value":94.17,"profit":true},{"date":"2023-06-30","value":99.85,"profit":true},{"date":"2024-06-30","value":93.68,"profit":true}]
Operating Expenses4.75M7.29M3.64M4.72M9.14M[{"date":"2020-06-30","value":51.94,"profit":true},{"date":"2021-06-30","value":79.76,"profit":true},{"date":"2022-06-30","value":39.84,"profit":true},{"date":"2023-06-30","value":51.61,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Operating Income(2.92M)(7.19M)(3.12M)(3.57M)(5.80M)[{"date":"2020-06-30","value":-291691000,"profit":false},{"date":"2021-06-30","value":-719374300,"profit":false},{"date":"2022-06-30","value":-311741300,"profit":false},{"date":"2023-06-30","value":-356883800,"profit":false},{"date":"2024-06-30","value":-580111800,"profit":false}]
Total Non-Operating Income/Expense(31.93K)(430.04K)117.16K(111.00K)(815.66K)[{"date":"2020-06-30","value":-27.25,"profit":false},{"date":"2021-06-30","value":-367.06,"profit":false},{"date":"2022-06-30","value":100,"profit":true},{"date":"2023-06-30","value":-94.74,"profit":false},{"date":"2024-06-30","value":-696.19,"profit":false}]
Pre-Tax Income(2.93M)(8.38M)(2.85M)(3.79M)(6.94M)[{"date":"2020-06-30","value":-292720600,"profit":false},{"date":"2021-06-30","value":-838446500,"profit":false},{"date":"2022-06-30","value":-285425400,"profit":false},{"date":"2023-06-30","value":-378650700,"profit":false},{"date":"2024-06-30","value":-693695700,"profit":false}]
Income Taxes(22.43K)13.76K(263.16K)(314.69K)(764.98K)[{"date":"2020-06-30","value":-162.96,"profit":false},{"date":"2021-06-30","value":100,"profit":true},{"date":"2022-06-30","value":-1912.35,"profit":false},{"date":"2023-06-30","value":-2286.81,"profit":false},{"date":"2024-06-30","value":-5559.05,"profit":false}]
Income After Taxes(2.90M)(8.40M)(2.59M)(3.47M)(6.17M)[{"date":"2020-06-30","value":-290478100,"profit":false},{"date":"2021-06-30","value":-839822600,"profit":false},{"date":"2022-06-30","value":-259109500,"profit":false},{"date":"2023-06-30","value":-347181900,"profit":false},{"date":"2024-06-30","value":-617197600,"profit":false}]
Income From Continuous Operations(2.93M)(8.38M)(2.85M)(3.79M)(6.94M)[{"date":"2020-06-30","value":-292720600,"profit":false},{"date":"2021-06-30","value":-838446500,"profit":false},{"date":"2022-06-30","value":-285425400,"profit":false},{"date":"2023-06-30","value":-378650700,"profit":false},{"date":"2024-06-30","value":-693695700,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Net Income(2.90M)(8.40M)(2.59M)(3.79M)(6.94M)[{"date":"2020-06-30","value":-290478100,"profit":false},{"date":"2021-06-30","value":-839822600,"profit":false},{"date":"2022-06-30","value":-259109500,"profit":false},{"date":"2023-06-30","value":-378650700,"profit":false},{"date":"2024-06-30","value":-693695700,"profit":false}]
EPS (Diluted)(0.02)(0.02)---[{"date":"2020-06-30","value":-1.75,"profit":false},{"date":"2021-06-30","value":-1.9,"profit":false},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

IMRN
Cash Ratio 4.32
Current Ratio 5.46
Quick Ratio 4.87

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

IMRN
ROA (LTM) -17.37%
ROE (LTM) -42.92%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

IMRN
Debt Ratio Lower is generally better. Negative is bad. 0.18
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.82

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

IMRN
Trailing PE NM
Forward PE NM
P/S (TTM) 2.36
P/B 1.41
Price/FCF NM
EV/R 1.47
EV/Ebitda 0.77
PEG NM

FAQs

What is Immuron Ltd ADR share price today?

Immuron Ltd ADR (IMRN) share price today is $1.97

Can Indians buy Immuron Ltd ADR shares?

Yes, Indians can buy shares of Immuron Ltd ADR (IMRN) on Vested. To buy Immuron Ltd ADR from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in IMRN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Immuron Ltd ADR be purchased?

Yes, you can purchase fractional shares of Immuron Ltd ADR (IMRN) via the Vested app. You can start investing in Immuron Ltd ADR (IMRN) with a minimum investment of $1.

How to invest in Immuron Ltd ADR shares from India?

You can invest in shares of Immuron Ltd ADR (IMRN) via Vested in three simple steps:

  • Click on Sign Up or Invest in IMRN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Immuron Ltd ADR shares
What is Immuron Ltd ADR 52-week high and low stock price?

The 52-week high price of Immuron Ltd ADR (IMRN) is $5.96. The 52-week low price of Immuron Ltd ADR (IMRN) is $1.59.

What is Immuron Ltd ADR price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Immuron Ltd ADR (IMRN) is

What is Immuron Ltd ADR price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Immuron Ltd ADR (IMRN) is 1.41

What is Immuron Ltd ADR dividend yield?

The dividend yield of Immuron Ltd ADR (IMRN) is 0.00%

What is the Market Cap of Immuron Ltd ADR?

The market capitalization of Immuron Ltd ADR (IMRN) is $11.17M

What is Immuron Ltd ADR’s stock symbol?

The stock symbol (or ticker) of Immuron Ltd ADR is IMRN

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top